(SBH) Sally Beauty Holdings - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US79546E1047

Stock: Hair Color, Hair Care, Styling Tools, Nail Care, Skin Care

Total Rating 56

Risk 89

Buy Signal 0.33

Specialty Retail » Other Specialty Retail
Age: 19.2y

Market Cap: 1,496m
Avg Trading Vol: 25.0M USD

ATR: 4.44%
Peers RS (IBD): 81.82

EPS (Earnings per Share)

EPS CAGR: -47.52%
EPS Trend: -43.2%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -0.91%
Rev. Trend: -40.0%

Last SUE: 1.77
Qual. Beats: 1

Risk 5d forecast
Volatility	49.5%
Relative Tail Risk	-6.80%

Reward TTM
Sharpe Ratio	1.04
Alpha	37.33

Character TTM
Beta	0.916
Beta Downside	0.443

Drawdowns 3y
Max DD	58.59%
CAGR/Max DD	-0.03

Description: SBH Sally Beauty Holdings January 21, 2026

Sally Beauty Holdings (NYSE:SBH) is a specialty retailer and distributor of professional beauty products operating through two segments: Sally Beauty Supply, which serves retail consumers, salons, and professionals with brands such as Wella and L’Oréal; and Beauty Systems Group, which supplies salons and licensed beauty professionals via professional-only stores, e-commerce, a sales force, and franchised Armstrong McCall locations, featuring brands like Paul Mitchell and Wella. The company’s footprint spans the United States, Puerto Rico, Canada, Mexico, Chile, the United Kingdom, Ireland, Belgium, France, the Netherlands, and Germany, and it reaches customers through company-operated stores, digital platforms, and both full-service and open-line distributors.

Key recent metrics show FY 2023 revenue of roughly $2.0 billion, with comparable-store sales up about 5% year-over-year and e-commerce accounting for ~30% of total sales-a trend that mirrors the broader beauty sector’s shift toward online purchasing. The business is sensitive to consumer discretionary spending and the health of the professional salon market, which historically grows at a 4-5% CAGR globally and benefits from rising “self-care” spending. Sally Beauty maintains a moderate leverage profile (debt-to-equity ≈ 0.6) and an operating margin near 5%, providing some cushion against macro-economic headwinds.

For a deeper dive into SBH’s valuation nuances and scenario analysis, you might find ValueRay’s research tools worth exploring.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income: 195.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.81 > 1.0
NWC/Revenue: 19.60% < 20% (prev 19.17%; Δ 0.43% < -1%)
CFO/TA 0.10 > 3% & CFO 274.8m > Net Income 195.9m
Net Debt (1.41b) to EBITDA (402.0m): 3.52 < 3
Current Ratio: 2.26 > 1.5 & < 3
Outstanding Shares: last quarter (101.8m) vs 12m ago -3.40% < -2%
Gross Margin: 51.62% > 18% (prev 0.51%; Δ 5111 % > 0.5%)
Asset Turnover: 130.7% > 50% (prev 133.1%; Δ -2.39% > 0%)
Interest Coverage Ratio: 4.69 > 6 (EBITDA TTM 402.0m / Interest Expense TTM 64.4m)

Altman Z'' 3.80

A: 0.25 (Total Current Assets 1.30b - Total Current Liabilities 576.0m) / Total Assets 2.87b
B: 0.31 (Retained Earnings 898.1m / Total Assets 2.87b)
C: 0.11 (EBIT TTM 302.1m / Avg Total Assets 2.83b)
D: 0.38 (Book Value of Equity 794.2m / Total Liabilities 2.08b)
Altman-Z'' Score: 3.80 = AA

Beneish M -2.86

DSRI: 1.27 (Receivables 116.6m/92.2m, Revenue 3.70b/3.72b)
GMI: 0.99 (GM 51.62% / 50.86%)
AQI: 0.98 (AQ_t 0.22 / AQ_t-1 0.23)
SGI: 1.00 (Revenue 3.70b / 3.72b)
TATA: -0.03 (NI 195.9m - CFO 274.8m) / TA 2.87b)
Beneish M-Score: -2.86 (Cap -4..+1) = A

What is the price of SBH shares?

As of February 04, 2026, the stock is trading at USD 16.55 with a total of 1,932,610 shares traded.
Over the past week, the price has changed by +8.81%, over one month by +10.92%, over three months by +15.90% and over the past year by +57.62%.

Is SBH a buy, sell or hold?

Sally Beauty Holdings has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold SBH.

StrongBuy: 2
Buy: 0
Hold: 2
Sell: 0
StrongSell: 1

What are the forecasts/targets for the SBH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	17.2	3.9%
Analysts Target Price	17.2	3.9%
ValueRay Target Price	19.3	16.7%

SBH Fundamental Data Overview February 01, 2026

P/E Trailing = 8.0529
P/E Forward = 7.3421
P/S = 0.4041
P/B = 1.8708
P/EG = 1.037
Revenue TTM = 3.70b USD
EBIT TTM = 302.1m USD
EBITDA TTM = 402.0m USD
Long Term Debt = 862.0m USD (from longTermDebt, last quarter)
Short Term Debt = 162.6m USD (from shortTermDebt, last quarter)
Debt = 1.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.41b USD (from netDebt column, last quarter)
Enterprise Value = 2.91b USD (1.50b + Debt 1.56b - CCE 149.2m)
Interest Coverage Ratio = 4.69 (Ebit TTM 302.1m / Interest Expense TTM 64.4m)
EV/FCF = 16.85x (Enterprise Value 2.91b / FCF TTM 172.7m)
FCF Yield = 5.94% (FCF TTM 172.7m / Enterprise Value 2.91b)
FCF Margin = 4.67% (FCF TTM 172.7m / Revenue TTM 3.70b)
Net Margin = 5.29% (Net Income TTM 195.9m / Revenue TTM 3.70b)
Gross Margin = 51.62% ((Revenue TTM 3.70b - Cost of Revenue TTM 1.79b) / Revenue TTM)
Gross Margin QoQ = 52.17% (prev 51.54%)
Tobins Q-Ratio = 1.01 (Enterprise Value 2.91b / Total Assets 2.87b)
Interest Expense / Debt = 0.96% (Interest Expense 15.0m / Debt 1.56b)
Taxrate = 23.17% (15.1m / 65.0m)
NOPAT = 232.1m (EBIT 302.1m * (1 - 23.17%))
Current Ratio = 2.26 (Total Current Assets 1.30b / Total Current Liabilities 576.0m)
Debt / Equity = 1.97 (Debt 1.56b / totalStockholderEquity, last quarter 794.2m)
Debt / EBITDA = 3.52 (Net Debt 1.41b / EBITDA 402.0m)
Debt / FCF = 8.19 (Net Debt 1.41b / FCF TTM 172.7m)
Total Stockholder Equity = 728.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.92% (Net Income 195.9m / Total Assets 2.87b)
RoE = 26.89% (Net Income TTM 195.9m / Total Stockholder Equity 728.4m)
RoCE = 19.00% (EBIT 302.1m / Capital Employed (Equity 728.4m + L.T.Debt 862.0m))
RoIC = 14.25% (NOPAT 232.1m / Invested Capital 1.63b)
WACC = 4.92% (E(1.50b)/V(3.06b) * Re(9.29%) + D(1.56b)/V(3.06b) * Rd(0.96%) * (1-Tc(0.23)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.25%
[DCF Debug] Terminal Value 86.99% ; FCFF base≈161.8m ; Y1≈173.3m ; Y5≈210.6m
Fair Price DCF = 49.06 (EV 6.23b - Net Debt 1.41b = Equity 4.82b / Shares 98.3m; r=5.90% [WACC]; 5y FCF grow 8.00% → 2.90% )
EPS Correlation: -43.22 | EPS CAGR: -47.52% | SUE: -4.0 | # QB: 0
Revenue Correlation: -40.03 | Revenue CAGR: -0.91% | SUE: 1.77 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.45 | Chg30d=+0.002 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-09-30): EPS=2.07 | Chg30d=+0.008 | Revisions Net=+1 | Growth EPS=+8.8% | Growth Revenue=+1.0%
EPS next Year (2027-09-30): EPS=2.24 | Chg30d=+0.012 | Revisions Net=+1 | Growth EPS=+8.4% | Growth Revenue=+1.7%

Additional Sources for SBH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle